WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has entered into an agreement with ...
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement ...
PerkinElmer has a competitive advantage in up-stream clinical research that addresses the initial and discovery phase before clinical trials and manufacturing of drugs, stemming from switching costs ...
NEW YORK, Oct 1 (Reuters) - PerkinElmer Inc said on Monday it has agreed to buy ViaCell Inc for $300 million in deal that will expand its fast-growing genetic screening business with the addition of ...
Starting this year, PerkinElmer is aligning its business to focus on two strategic areas—human health and environmental health. The new emphasis better defines the strategic mission of the company and ...
Perkinelmer Inc. has agreed to acquire in vitro diagnostics company Immunodiagnostic Systems Holdings plc (IDS) for approximately $155 million (£110 million). The deal will enable Perkinelmer to ...
PerkinElmer Fluid Sciences launched a series of web-based design tools that allow customers to configure some of their PerkinElmer products online. One tool applies for configuring static seals used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results